AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 262 min read$TSLA

Scott Galloway on Tesla and SpaceX: “Tesla’s the Patient and SpaceX Is the Organ Donor”

Barclays upgraded Tesla to Overweight, raising its price target to $450, citing a potential merger with SpaceX as a key bull case. Tesla shares rose 6% on the news. Scott Galloway argued the deal would benefit Tesla shareholders at SpaceX's expense. Tesla's earnings per share fell from $3.12 in 2023 to $1.66 in 2025, with a forward P/E above its three-year average.

Original reporting
finance.yahoo.com
Published Oct 26, 2026, 6:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 6:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Scott Galloway on Tesla and SpaceX: “Tesla’s the Patient and SpaceX Is the Organ Donor” — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$TSLABullishMed
01

Why it matters

The upgrade triggered a 6% intraday rally, indicating immediate market reaction to the new rating.

02

Market read

Tesla's stock moved sharply on the upgrade, making the news highly relevant for short‑term traders.

03

What to watch

Tesla's declining earnings and high forward P/E may limit upside despite the upgrade.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Barclays analyst Dan Levy treated the potential Tesla‑SpaceX merger as effectively settled, raising Tesla's target and rating.

Company-level read

Ticker impact

$TSLABullishHigh confidence
Context

Barclays upgraded Tesla to Overweight and raised its price target to $450, prompting a 6% share jump.

Expected impact

likely upward pressure as traders price in the higher target and overweight rating

Evidence & confidence

Barclays' upgrade is a fresh analyst action with a concrete price target increase, which typically drives buying interest.

Market effects

Sector

The upgrade may lift other EV and autonomous‑vehicle stocks as investors reassess sector outlook.

Regional

U.S. equity markets could see modest gains in tech‑heavy indices.

Global

Limited to markets tracking U.S. tech; no direct global ripple.

Counterpoint

What could challenge this read

The merger speculation remains unconfirmed; the upgrade could be premature if the deal stalls.

Key entities

  • Company
    Tesla

    Electric vehicle and energy company receiving the upgrade.

  • Financial Institution
    Barclays

    Analyst firm that issued the upgrade and new price target.

Read at source← All news

StoryBarclays upgrades Tesla to Overweight and raises price target to $450, citing SpaceX merger potential

Also covered by

5 outlets

Related articles

OCT 26
$TSLAHighAI 8/10

TSLA Breaks Above Resistance as Barclays Upgrades Tesla Stock Citing Potential SpaceX Merger and Delivery Growth Supports Bullish Outlook

Tesla (TSLA) shares rose to near $400 after Barclays upgraded its price target to $450, citing strong vehicle deliveries and potential SpaceX merger. Q3 earnings beat estimates, but rising capital expenditure raises concerns. Deliveries exceeded expectations, with mixed regional demand. Technical resistance at $400 remains a key level.

fxleaders.com3 min
OCT 26
$TSLAMedAI 9/10

Elon Musk Says He'd Be 'Stunned' If Any Robot Rivals Optimus At Launch: Gene Munster Calls It A Tesla 'Call Option' With 'Massive Value'

Tesla CEO Elon Musk stated that Optimus, the company's humanoid robot, will have unscripted demonstrations soon, with deliveries to industrial customers expected by late 2027. Musk expressed confidence that no rival will match Optimus at launch. Tesla reported Q3 revenue of $28.05 billion, slightly above estimates, with adjusted earnings of 48 cents per share. Analyst Gene Munster views Optimus as a valuable 'call option' for Tesla.

finance.yahoo.com2 min
OCT 26
$TSLALow

Tesla's Bet: Robotaxis, Robots, and a SpaceX Merger

Tesla's Q2 2026 revenue from automotive operations fell 3% YoY to $20.56B. Operating margin dropped to 1.4% from 4.1% YoY, missing expectations. Operating expenses rose 47% to $4.35B, with capex up 142% to $5.79B. Tesla is focusing on AI, Robotaxi, and Optimus robot, with Robotaxi service expanding in select U.S. cities. FSD subscriptions grew 56% QoQ to 1.48M. A potential SpaceX merger was discussed but not confirmed.

thetruthaboutcars.com5 min
OCT 26
$TSLAHigh

Tesla Stock Soars on Wave of Analyst Upgrades

Tesla's stock rose 6% to $394.5 after Barclays upgraded it to Overweight with a $450 price target, citing improving business trends and potential SpaceX merger. Mizuho also raised its target to $460. The rally follows Tesla's strong quarterly results and investor interest in its autonomous-driving initiatives.

gurufocus.com2 min
OCT 26
$TSLAMed

Tesla stock leaves rest of the Magnificent 7 in the dust, surging to October’s top spot

Tesla (TSLA) stock rose 6% on Monday, its best day since July, driven by a Barclays upgrade suggesting a potential merger with SpaceX (SPCX). Barclays raised its price target to $450. Tesla's October performance is the best among the Magnificent 7, though it remains down double digits for the year. The stock broke through its 200-day moving average, a key technical level. Musk confirmed talks of a Tesla-SpaceX combination, but no deal has been announced.

finance.yahoo.com2 min
OCT 26
$TSLAHigh

Tesla Barclays Upgrade: Up 6%, Lucid Down 4% [2026]

Tesla shares rose 5-6% on October 26, 2026, after Barclays upgraded its stock to Overweight and raised its price target to $450, citing potential merger with SpaceX. Lucid Group and Rivian Automotive fell 4% and 2% respectively, with no specific news reported. Barclays analyst Dan Levy attributed the upgrade to expected merger premium, not Tesla's core business. The merger is not confirmed, and committees are discussing the potential combination.

tech-insider.org2 min